Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.94
- Piotroski Score 5.00
- Grade Overweight
- Symbol (INMD)
- Company InMode Ltd.
- Price $19.01
- Changes Percentage (2.84%)
- Change $0.53
- Day Low $18.41
- Day High $19.13
- Year High $26.80
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/11/2025
- Fiscal Year End N/A
- Average Stock Price Target $22.50
- High Stock Price Target $58.00
- Low Stock Price Target $16.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.11
- Trailing P/E Ratio 8.65
- Forward P/E Ratio 8.65
- P/E Growth 8.65
- Net Income $197.92 M
Income Statement
Quarterly
Annual
Latest News of INMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
InMode's stock has risen by 3.3% recently, prompting an analysis of its Return on Equity (ROE). With a ROE of 20%, higher than the industry average of 11%, InMode's efficient reinvestment of capital h...
By Yahoo! Finance | 1 month ago -
InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now
A recent article compares InMode (NASDAQ:INMD) against other Middle East and Africa stocks. Despite economic challenges in the MENA region, investments in private equity and venture capital are growin...
By Yahoo! Finance | 2 months ago -
InMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts?
InMode (NASDAQ: INMD) is a leading Israeli medical technology company specializing in radio-frequency treatments. Despite recent challenges, the company remains a strong investment with innovative pro...
By Yahoo! Finance | 2 months ago
